These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11187651)

  • 81. The PSIP approach to account for human factors in Adverse Drug Events: preliminary field studies.
    Riccioli C; Leroy N; Pelayo S
    Stud Health Technol Inform; 2009; 148():197-205. PubMed ID: 19745251
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Contradictions in contraindications for drug-drug interactions.
    Shah VS; Weber RJ; Nahata MC
    Ann Pharmacother; 2011 Mar; 45(3):409-11. PubMed ID: 21386019
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Necessity of clinical decision support system created by medical staff].
    Yamamoto Y
    Rinsho Byori; 2011 May; 59(5):519-26. PubMed ID: 21706869
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Interpersonal communication as a factor in successful development of a decision-oriented information systems model in the hospital].
    von Eiff W; Ziegenbein R
    Zentralbl Gynakol; 1999; 121(11):537-42. PubMed ID: 10612222
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Coherent exchange of healthcare knowledge in open systems.
    Buchan I; Hanka R
    Stud Health Technol Inform; 1997; 43 Pt B():821-4. PubMed ID: 10179782
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Method for evaluating drug information systems.
    Laning LJ; Leonard MS; Mullins PM
    Am J Hosp Pharm; 1979 Jun; 36(6):793-6. PubMed ID: 463897
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Using knowledge base systems in healthcare.
    Hapgood W
    Healthc Inform; 1991 Jul; 8(7):37-8, 41. PubMed ID: 10120825
    [No Abstract]   [Full Text] [Related]  

  • 88. [Adverse psychological drug effects. Methodological problems in detection and examples from clinical practice].
    Hollweg M; Krupinski M; Steinwachs A
    Med Monatsschr Pharm; 1997 Feb; 20(2):36-43. PubMed ID: 9132536
    [No Abstract]   [Full Text] [Related]  

  • 89. Artificial intelligence--its use in nephrology.
    Degoulet P
    Nephrol Dial Transplant; 1987; 2(5):298-303. PubMed ID: 3122106
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Drug interaction microcomputer software evaluation: Drug Therapy Screening System (DTSS).
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Aug; 25(8):738-41, 744. PubMed ID: 10170582
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Design of a decision support system for preventive maintenance planning in health structures.
    Miniati R; Dori F; Gentili GB
    Technol Health Care; 2012; 20(3):205-14. PubMed ID: 22735735
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Reporting systems for rare side effects of non-narcotic analgesics in India. Problems and opportunities.
    Kulkarni RD
    Med Toxicol; 1986; 1 Suppl 1():110-3. PubMed ID: 3821424
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Pharmacoepidemiology in hospitals using automated data systems.
    Platt R; Stryker WS; Komaroff AL
    Am J Prev Med; 1988; 4(2 Suppl):39-47. PubMed ID: 3275179
    [No Abstract]   [Full Text] [Related]  

  • 95. Framework for quality assessment of knowledge.
    Brender J; Talmon J; McNair P
    Stud Health Technol Inform; 1995; 16():219-27. PubMed ID: 10163717
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Knowledge engineering for adverse drug event prevention: on the design and development of a uniform, contextualized and sustainable knowledge-based framework.
    Koutkias V; Kilintzis V; Stalidis G; Lazou K; Niès J; Durand-Texte L; McNair P; Beuscart R; Maglaveras N
    J Biomed Inform; 2012 Jun; 45(3):495-506. PubMed ID: 22326287
    [TBL] [Abstract][Full Text] [Related]  

  • 97. New guidelines prevent costly adverse drug reactions.
    Healthc Demand Dis Manag; 2000 Apr; 6(4):59-63, 49. PubMed ID: 11066296
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Mitigation of adverse interactions in pairs of clinical practice guidelines using constraint logic programming.
    Wilk S; Michalowski W; Michalowski M; Farion K; Hing MM; Mohapatra S
    J Biomed Inform; 2013 Apr; 46(2):341-53. PubMed ID: 23376273
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Drug interaction microcomputer software evaluation: the Medical Letter Drug Interactions Program.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 May; 25(5):458-61. PubMed ID: 10104826
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Knowledge acquisition environment for the design of a decision support system: application in blood transfusion.
    Achour SL; Dojat M; Rieux C; Bierling P; Lepage E
    Proc AMIA Symp; 1999; ():187-91. PubMed ID: 10566346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.